SynthesisJournal of neurology2025
Intra-arterial thrombolysis as rescue therapy for incomplete reperfusion following thrombectomy: a meta-analysis.
Synthesis in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Recanalization: A Mechanistic and Procedural Framework for Adjunct Pharmacologic Therapy During Mechanical Thrombectomy.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeMechanical thrombectomy (MT) is a primary treatment for acute ischemic stroke caused by large vessel occlusion. However, incomplete reperfusion is common and leads to poorer patient outcomes. Intra-arterial thrombolysis (IAT) is a potential rescue therapy, but its efficacy and safety remain controversial.
methodsA comprehensive literature search was performed across PubMed, Scopus, Web of Science, and Cochrane Library up to January 2025. The search included terms related to stroke, thrombectomy, thrombolysis, and intra-arterial. Studies comparing IAT as rescue therapy following MT with MT alone in patients with incomplete reperfusion were included. The primary outcome was functional independence (modified Rankin Scale [mRS] score of 0-2 at 90 days). Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated using a random-effects model. This meta-analysis followed PRISMA guidelines and was registered with PROSPERO (CRD420251063825).
resultsSeven studies, totaling 1893 patients (374 in MT + IAT; 1519 in MT alone) were included. Pooled analysis indicated that IAT as a rescue therapy was associated with significantly higher odds of functional dependence at 90 days (OR 1.40, 95% CI 1.06-1.83; p = 0.017) and lower 90-day mortality (OR 0.69, 95% CI 0.49-0.98; p = 0.036). There was no statistically significant increase in the risk of intracranial hemorrhage (OR 0.72, 95% CI 0.46-1.11; p = 0.132) or symptomatic intracranial hemorrhage (OR 1.10, 95% CI 0.59-2.03; p = 0.768) associated with IAT.
conclusionsIn patients with incomplete reperfusion after MT, IAT as rescue therapy improved functional outcomes and reduced mortality within 90 days, without increasing the risk of ICH or sICH.
Indexed as
Identifiers
40745037What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.